$84.840
-0.008 (-0.01%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CRNX Prediction & Forecast by Similar Chart Analysis
Alphio's CRNX stock price prediction model matches the current Crinetics Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $83.40 (-1.70%). The 1-week path is $85.33 (+0.58%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Crinetics Pharmaceuticals Inc Stock?
Crinetics Pharmaceuticals (CRNX) is currently trading at $84.84, very close to the analyst price target of $85. The RSI is at 82.058, indicating that the stock is overbought, which suggests caution for new buyers. The stock has shown a strong year-to-date change of +81.55% and a one-year change of +154.77%, reflecting significant growth. However, the forward P/E ratio is 0, indicating no earnings are expected in the near term, which is a risk for long-term investors. Given these factors, it's advisable to hold rather than buy at this moment, as the stock is near its acquisition price with limited upside potential.
CRNX stock price ended at $84.84 on Friday, after losing -0.01%
Crinetics Pharmaceuticals Inc (CRNX) last closed at $84.84, losing -0.01%. These facts feed the 1-day and 1-week CRNX price prediction above.
Analyst Consensus
Crinetics Pharmaceuticals Inc (CRNX): 2 buy, 1 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Crinetics Pharmaceuticals Inc (CRNX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches CRNX, ranked by similarity.
Seasonality analysis for CRNX
Historically the probability of a positive August return for CRNX is 66.67%. August offers the highest probability of a positive month at 66.67%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CRNX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $29.02 | $33.48 | $43.32 | -60.54% |
| Sep 2026 | $28.52 | $30.15 | $38.60 | -64.47% |
| Oct 2026 | $28.38 | $30.47 | $31.73 | -64.09% |
| Nov 2026 | $27.37 | $33.48 | $43.31 | -60.54% |
| Dec 2026 | $27.24 | $29.77 | $35.84 | -64.91% |
In 2026, Crinetics Pharmaceuticals Inc (CRNX) is projected to range from $27.24 to $43.32.
Crinetics Pharmaceuticals Inc 2026 monthly forecast
In Aug 2026, Crinetics Pharmaceuticals Inc is projected to average $33.48, with a low of $29.02 and high of $43.32.
In Sep 2026, Crinetics Pharmaceuticals Inc is projected to average $30.15, with a low of $28.52 and high of $38.60.
In Oct 2026, Crinetics Pharmaceuticals Inc is projected to average $30.47, with a low of $28.38 and high of $31.73.
In Nov 2026, Crinetics Pharmaceuticals Inc is projected to average $33.48, with a low of $27.37 and high of $43.31.
In Dec 2026, Crinetics Pharmaceuticals Inc is projected to average $29.77, with a low of $27.24 and high of $35.84.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.